Fig. 4

Establishment and evaluation of a nomogram survival model. (A) Univariate Cox regression analysis of clinical characteristics and LSCD score in the TCGA cohort. (B) Multivariate Cox regression analysis of clinical characteristics and LSCD score in the TCGA cohort. (C) Prognostic nomogram prediction model for TCGA patients. (D) Calibration plots for predicting 1-, 3-, and 5-year overall survival rates in the TCGA cohort. (E) Decision curve analysis for clinical characteristics and LSCD in the TCGA cohort. (F) Kaplan-Meier analysis of overall survival for high- and low-risk patients in the TCGA-LAML cohort based on the nomogram score. (G-I) ROC analysis of the 1-, 3-, and 5-year survival rates in AML patients in the (G) TCGA-LAML, (H) GSE146173, and (I) BeatAML cohorts.